Serum and plasma dopamine-beta-hydroxylase (DBH, E. C. 1. 14. 17. 1.) activity has been measured by several investigators in order to assess its value for the diagnosis of neural crest tumours. In children with neuroblastoma both elevated and normal values have been reported (Goldstein et al., 1972; Brewster et al., 1979) . Recently Eldeeb et al. (1983) published evidence indicating that the DBH activity is related neither to the disease state nor to the urinary catecholamine output. These authors concluded that this enzyme has no diagnostic value and is poorly correlated to tumour growth. As shown below our results support the conclusions of Eldeeb et al. (1983) and suggest that the procedure used to determine serum DBH activities might be inadequate. For DBH assays a convenient spectrophotometric method, initially described by Nagatsu & Udenfriend (1972), has been widely used. The inability to detect low DBH activity levels in laboratory animals or in humans with genetically low DBH activity demonstrates, however, that this method lacks sensitivity. In addition strong interindividual variability was noticed (Weinshilboum, 1978).
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The original description of Nagatsu and Udenfriend's assay prescribes incubation of 2-50pl human serum or plasma diluted with water to 400p1 in a standard incubation mixture containing sodium acetate buffer (1moll-', pH, 5.0) Received 26 May 1983; accepted 13 October 1983. disposable Pasteur pipette. The tube and the precipate are washed with 1ml of distilled water which is also transferred to the column. After washing the column twice with 2 ml of distilled water the adsorbed amines are eluted with 1 ml of 4 M NH40H. In the elute tyramine derived octopamine is converted to p-hydroxy-benzaldehyde by adding 0.1 ml of NaIO4 solution (20 g 1-1). Excess perjodate is then reduced by 0.1 ml Na2S2O0 (100 g -1) and the absorbance is measured against water at 330 nm in a semimicrocuvet with a 1 cm light path (Zeiss PQM TI).
For the repeated determinations of the same material (intra-batch) a coefficient of variation (CV) varying between 1.8% (Nagatsu & Udenfriend, 1972) and 3% (Eldeeb et al., 1983) has been indicated. Since in our hands the CV was considerably higher we tested the method with standard concentrations of octopamine. Increasing amounts of octopamine were transferred to the columns and the recovery after elution with 1.Oml NH40H (=No. 1 eluate) was 98.0+4.2% for columns packed with Dowex 5OW, 8X (mesh 200-400) (n=30) and 79.1+8.2% for columns packed with Dowex 5OW, 12X (mesh 200-400) (same n). Following a second wash with 1.0 ml NH40H (=No. 2 eluate) no further recovery was obtained with the Dowex 50WW, 8X, but an additional recovery of 20% was obtained with Dowex 50W,12X columns. It was also noticed that up to 60 nmol octopamine the recovery from the columns was nearly linear to the standard curve (octopamine in 1.0ml of 4M ammonium carried only through the oxidation procedure). When higher concentrations of octopamine were loaded on the columns the recovery in the first eluate decreased but increased in the second eluate.
For intra-batch analysis we used heparinized plasma and tested 20-30 columns with lOul of plasma per column. The results of these assays are summarized in Table I : First, the recovery of the activity from the Dowex 50W,8X column in the first eluate (El, first ml of ammonia to wash the columns) is significantly lower for plasma samples than for pure octopamine solutions: Second, in all experiments the No. 1 eluate recovers only 70-85% of the overall activity (T): Third, there is a wide range of results obtained with the same plasma batch and fourth, the CV characterizing the reproducibility of activity determinations in the first eluate varies between 7.5 and 19%. This range can be decreased to 4.8-14% by a second washing.
For day to day subsequent reproducibility (interbatch) a similar variability was observed.
Despite these methodological implications we studied plasma DBH activity in 29 children (age 0.5-15 years) without neurogenic tumour and in 20 children (age 0.1-8 years) with proven neuroblastoma.
As described by others an age dependent increase of the values was found. There was no correlation, however, between activity levels and the diagnosis of neuroblastoma or the state of disease. As noticed by Eldeeb et al. (1983) , DBH activity determinations are therefore not helpful for the diagnosis of neuroblastoma. It is questionable, furthermore, whether the spectrophotometric assay widely used is sensitive enough and since other procedures do not seem to provide more reliable information (Weinshilboum, 1979) conclusions based on the measurements of DBH activities should be interpreted accordingly.
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